机译:在手术治疗肾细胞癌患者中评估伴随的非肿瘤药物:对预后,细胞周期进展和增殖的影响
Eberhard Karls Univ Tubingen Dept Urol Hoppe Seyler Str 3 D-72076 Tubingen Germany;
Eberhard Karls Univ Tubingen Dept Urol Hoppe Seyler Str 3 D-72076 Tubingen Germany;
Eberhard Karls Univ Tubingen Dept Urol Hoppe Seyler Str 3 D-72076 Tubingen Germany;
Dr Margarete Fischer Bosch Inst Clin Pharmacol Stuttgart Germany;
Dr Margarete Fischer Bosch Inst Clin Pharmacol Stuttgart Germany;
Eberhard Karls Univ Tubingen Dept Urol Hoppe Seyler Str 3 D-72076 Tubingen Germany;
Eberhard Karls Univ Tubingen Dept Pathol Tubingen Germany;
Eberhard Karls Univ Tubingen Dept Urol Hoppe Seyler Str 3 D-72076 Tubingen Germany;
Eberhard Karls Univ Tubingen Dept Pathol Tubingen Germany;
Eberhard Karls Univ Tubingen Dept Urol Hoppe Seyler Str 3 D-72076 Tubingen Germany;
Eberhard Karls Univ Tubingen Dept Urol Hoppe Seyler Str 3 D-72076 Tubingen Germany;
Eberhard Karls Univ Tubingen Dept Urol Hoppe Seyler Str 3 D-72076 Tubingen Germany;
HGM-CoA reductase inhibitor; Nephrectomy; Nephron sparing surgery; Renal cell carcinoma; Clear cell; Statin; Localized; Sartan; Angiotensin receptor blockers; Concomitant medication; Ki67; Cyclin D1; Proliferation marker; Cell cycle;
机译:在手术治疗肾细胞癌患者中评估伴随的非肿瘤药物:对预后,细胞周期进展和增殖的影响
机译:SARCAMATOID分化和rhabdoid分化对手术治疗肾细胞癌肾细胞癌预后的影响
机译:Sulfatase-2对肾细胞癌患者癌症进展和预后的影响
机译:转移性肾细胞癌:预后,预测,基因组学
机译:通过膜结合的磷脂酰肌醇通过膜结合O-酰基转移酶结构域-7(MBOAT7)促进透明细胞肾细胞癌的进展(CCRCC)
机译:帕唑帕尼联合调pH药物对转移性肾细胞癌患者无进展生存期和总生存期的影响
机译:PD12-01与非抗癌药物的共同用药影响手术治疗的透明细胞肾细胞癌患者的结果吗? - 评估存活,细胞周期活性和增殖